Predicting early vs late vs no re-exacerbation in COPD patients:Analysis of ECLIPSE cohort

M. Fahey (London, United Kingdom), W. Meeraus (London, United Kingdom), C. El Baou (London, United Kingdom), H. Mullerova (London, United Kingdom), E. M. Hessel (London, United Kingdom), W. A. Fahy (London, United Kingdom)

Source: International Congress 2019 – Exacerbations of airway diseases
Session: Exacerbations of airway diseases
Session type: Poster Discussion
Number: 5223
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Fahey (London, United Kingdom), W. Meeraus (London, United Kingdom), C. El Baou (London, United Kingdom), H. Mullerova (London, United Kingdom), E. M. Hessel (London, United Kingdom), W. A. Fahy (London, United Kingdom). Predicting early vs late vs no re-exacerbation in COPD patients:Analysis of ECLIPSE cohort. 5223

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors associated with prolonged duration of AECOPD:Analysis of the ECLIPSE cohort
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

Extent and impact of late vs early stage COPD diagnosis in the Swedish ARCTIC study
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020
Year: 2021



Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort
Source: International Congress 2017 – COPD: latest insights into the management of patients
Year: 2017


Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort.
Source: International Congress 2017 – Markers of COPD progression
Year: 2017


Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
Source: Eur Respir J 2013; 42: 636-646
Year: 2013



Identification of distinct trajectories of FEV1 progression in the ECLIPSE cohort
Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine
Year: 2021



Comparison of LAMA/LABA vs ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial
Source: International Congress 2018 – COPD management
Year: 2018


REducing Delay through edUcation on eXacerbations (REDUX) in patients with COPD
Source: International Congress 2018 – Primary care management of COPD
Year: 2018


Late Breaking Abstract - Extrafine triple therapy reduces exacerbations in GOLD B COPD patients: post-hoc analysis of TRILOGY and TRINITY
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017



Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO study – interim analysis)
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008


LATE-BREAKING ABSTRACT: Elevated cardiovascular risk as measured by QRISK2 score in patients hospitalized for acute COPD exacerbation versus stable COPD outpatients
Source: International Congress 2014 – Comorbidities
Year: 2014


Fatty liver infiltration in patients with COPD. An ECLIPSE cohort study
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016

A comparison of COPD patients with and without ACOS in the ECLIPSE study
Source: Eur Respir J 2016; 47:1559-1562
Year: 2016


Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019


Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening
Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS
Year: 2018



Characteristics of adult onset vs. late onset asthma - a multinational database cohort study
Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics
Year: 2017



Predictors of mortality in a well-characterised group of patients with COPD
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012